Factors influencing long term outcomes after elective surgical intervention remain poorly studied. One recent study (Lamberink et al., 2020) addressed this issue analysing the association between histopathology and seizure outcome and drug freedom up to 5 years after epilepsy surgery.
Category
Research Highlights
-
-
Panel Autonomic Nervous System Disorders has published a neurology update
-
Evaluating blood pressure and heart rate changes upon standing helps screening for nOH at bedside.
-
A paper has just been published – Collaboration between palliative care and neurology: a survey of clinicians in Europe.
-
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients
-
New-onset seizures in the context of SARS-CoV-2 infection
-
Epilepsy care during the COVID-19 pandemic
-
Disability through COVID-19 pandemic: Neurorehabilitation cannot wait
-
Palliative care in neurology
-
DIRECT-MT: Should stroke patients selected for mechanical thrombectomy also receive intravenous thrombolysis?
-
Research HighlightsEAN NewsCOVID-19ResearchTop Articles
Neurology Update: Epilepsy & Covid-19
July 14, 2020Acute symptomatic seizures and SARS-CoV-2 encephalitis in COVID-19 -
Research HighlightsEAN NewsCOVID-19ResearchTop Articles
Neurology Update: COVID-19 & Neuroscience/ Translational neurology
July 7, 2020COVID Breaking news: CNS injury biomarkers elevated in COVID patients -
New randomised control trial evidence for treatment of status epilepticus
-
A new guideline on the palliative care for people with severe multiple sclerosis has been produced by EAN, in collaboration with ...
-
Research HighlightsResearch
Neurology Update: Adjunctive cenobamate for uncontrolled focal epilepsy in adults: phase II trial results
June 12, 2020A double-blind, randomised, placebo-controlled phase II study of adjunctive cenobamate in adults with uncontrolled focal epilepsy showed high rates of total seizure-freedom over 12 weeks.
